Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sciele Pharma has submitted a supplemental new drug application to the FDA for a new formulation of Sular.
Subscribe to our email newsletter
The new formulation utilizes SkyePharma’s patented Geomatrix technology, which has been developed to provide a lower dose of Sular for each of its current doses.
Sular is designed to control high blood pressure.